Shares of Affymax (AFFY -9.1%) become unhinged with a sudden 17% nosedive before they track back...

|By:, SA News Editor

Shares of Affymax (AFFY -9.1%) become unhinged with a sudden 17% nosedive before they track back up again. Much of the speculation over the company has centered on whether its anemia drug Peginesatide will land FDA approval.